[fcb5af]: / literature / by_gene_clean / NFKBIE.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 35885481 10.3390/diagnostics12071575 2022 Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma. NFKBIE
2 35964234 10.1093/ajcp/aqac087 2022 Histiocytic Sarcoma With CCND1 Gene Rearrangement Clonally Related and Transdifferentiated From Mantle Cell Lymphoma. NFKBIE
3 32079702 10.3324/haematol.2019.237719 2021 Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study. NFKBIE
4 32961552 10.1182/blood.2020007507 2021 Mutational landscape of gray zone lymphoma. NFKBIE
5 34405005 10.7150/jca.60390 2021 Serial surveillance by circulating tumor DNA profiling after chimeric antigen receptor T therapy for the guidance of r/r diffuse large B cell lymphoma precise treatment. NFKBIE
6 32012328 10.1002/hon.2718 2020 High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas. NFKBIE
7 32585984 10.3390/cancers12061669 2020 Discovery of Novel Recurrent Mutations and Clinically Meaningful Subgroups in Nodal Marginal Zone Lymphoma. NFKBIE
8 32947237 10.1016/j.tranon.2020.100855 2020 Identification of clinical molecular targets for childhood Burkitt lymphoma. NFKBIE
9 29857068 10.1016/j.jid.2018.04.038 2018 Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type. NFKBIE
10 29899297 10.3390/ijms19061758 2018 Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib Therapy. NFKBIE
11 26647218 10.1158/1078-0432.CCR-15-2123 2016 Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas. NFKBIE
12 19573080 10.1111/j.1365-2141.2009.07790.x 2009 Common genetic variants in candidate genes and risk of familial lymphoid malignancies. NFKBIE
13 19773279 10.1136/oem.2008.044024 2009 Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. NFKBIE